(redirected from vagus nerve)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia, Wikipedia.
See: discursive
References in periodicals archive ?
The CardioFit system includes a pacemaker-like stimulator placed inside the upper chest and a proprietary nerve stimulation cuff placed on the right vagus nerve in the neck.
What our company has done is to take the proven treatment that is vagus nerve stimulation, and extract its therapeutic value from its prior delivery device, which was an expensive, surgically implanted device, and replaced it with a compact, inexpensive hand-held device which a patient can use wherever he or she may be.
Key clinical point: Adjunctive vagus nerve stimulation therapy in children with drug-resistant epilepsy reduces seizures.
It was found that denerving the vagus nerve through botox injections had the same effect as vagotomy that helped block the development of gastric cancer in the mice.
One of these treatments is a neurostimulation device--the vagus nerve stimulator.
More than 46,000 patients worldwide have benefited from vagus nerve stimulation therapy during the past 10 years.
The Food and Drug Administration approved vagus nerve stimulation (VNS) in 2005 for adjunctive long-term treatment of chronic or recurrent depression in patients aged 18 years or older who do not have an adequate response to four or more antidepressant therapies.
The vagus nerve originates in the brain stem, specifically the nucleus ambiguus of the medulla.
The Vagus Nerve Stimulator (VNS) uses electrical impulses delivered by a generator implanted in the chest to two tiny leads wrapping around the nerve in the neck.
Clinical trials show that vagus nerve stimulation (VNS) therapy--commonly called a "pacemaker for the brain"--may help reduce the number, length, and severity of seizures in those people.
Recent advances in biomedical technology and perfection in surgical techniques have shown vagus nerve stimulation (VNS[TM]) using the Neuro Cybernetic Prosthesis (NCP[R]) system is an effective new treatment option in reducing seizure frequency.
BioControl Medicalhas announced that the pilot clinical study of its CardioFit[R] vagus nerve stimulation system has been recognized as seminal original research in the European Journal of Heart Failure.